Replimune Group Stock (NASDAQ: REPL) stock price, news, charts, stock research, profile.
Open | $10.97 |
Close | - |
Volume / Avg. | 674.64K / 862.32K |
Day Range | $10.67 - $11.15 |
52 Wk Range | 4.92 - 17.89 |
Market Cap | $748.80M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 11.09% |
Days to Cover | 9.69 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Replimune Group (NASDAQ:REPL) through any online brokerage.
Other companies in Replimune Group’s space includes: 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Tango Therapeutics (NASDAQ:TNGX) and Mesoblast (NASDAQ:MESO).
Replimune Group has a consensus price target of $36.50.
The stock price for Replimune Group (NASDAQ: REPL) is $10.96 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Replimune Group.
Replimune Group’s Q2 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Replimune Group.
Replimune Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.